chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Mar2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 45 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2022, outcome "recovering" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
migraines; swollen arm; red arm; severe headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraines), PERIPHERAL SWELLING (swollen arm), ERYTHEMA (red arm) and HEADACHE (severe headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21) for COVID-19 immunisation.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced MIGRAINE (migraines), PERIPHERAL SWELLING (swollen arm), ERYTHEMA (red arm) and HEADACHE (severe headache). At the time of the report, MIGRAINE (migraines) outcome was unknown and PERIPHERAL SWELLING (swollen arm), ERYTHEMA (red arm) and HEADACHE (severe headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included paracetamol.
Shot was given on Monday 9/20/2004 at approximately 3:50pm. By the next afternoon around 2:30pm patient began to feel lethargic, fever increased, pain in all joints, sweats, chills, lightheadedness with fever peaking out at 102 on Thursday 9/23/04.  By Friday evening 9/24/04, the fever went down to 99 which was the lowest since Tuesday.  During the early morning hours of 9/25/04 at 4:30am, I awaked in a wet bed with my hair all wet and perspiration just running off my body, the fever was at 102 again and still is at 11:25am.  I have been taking Tylenol 500mg X 2 since Tuesday and using cold compresses as instructed by the clinic.  I am still feeling miserable and have received flu vaccines for 15 years without any reactions like this.  If it goes any higher than 102, I will go to the emergency room. Patient additionally developed UTI; improving with antibiotics.
No adverse event; 1st dose -20-MAR-2021and 2nd dose-02-APR-2022; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose -20-MAR-2021and 2nd dose-02-APR-2022) and NO ADVERSE EVENT (No adverse event) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose -20-MAR-2021and 2nd dose-02-APR-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose -20-MAR-2021and 2nd dose-02-APR-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided          No concomitant medication were reported. No treatment information were provided.   This case was linked to MOD-2022-617420 (Patient Link).
6 inch red/swollen area on arm, nausea, vomiting, fever, headache. Has lasted 3 days so far.
Pt had fever to 102.8 and resultant seizure. ER visit revealed cath. u/a growing and ecoli (>20,000).
Patient had 2 doses of Pfizer vaccine on 4/28/21, and 5/19/21, and was admitted to the hospital on 12/17/21 for COVID symptoms and CHF exacerbation.
Whether by coincidence or a legitimate reaction, one week after the vaccination, a sore broke out on my back. It could best be described as a sore or small boil (it popped and was drained two times). It took between two and three weeks for it to become a small scar. Three weeks after the vaccination, an identical sore or small boil broke out between my upper lip and nose. The sore is now reduced in size and no longer painful. Even though this is the first time for such an event, no doctor was consulted.
Injection site redness and increase skin temp at site which occurred 8 days after 1st dose of vaccination.  No itching present. Slightly tender and no swelling at this time.
12/4/01- pt. noticed pain @ site, warm to the touch, increased pain into axillary site. this am noticed rash/hives. no c/o difficulty in breathing. will be using one benadryl 50 mg 6hr prn
Shingles; Started noticing bumps; Left eye swollen; Rash on his forehead above left eye; Bad headache on left side of head/Bad headache on left side of eye/ Headache lasted all night; Could not sleep; soreness in arm; Very Tired; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Could not sleep), EYE SWELLING (Left eye swollen), HERPES ZOSTER (Shingles), SKIN MASS (Started noticing bumps) and MYALGIA (soreness in arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027c21a and 027c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced MYALGIA (soreness in arm) and FATIGUE (Very Tired). On 02-Jun-2021, the patient experienced INSOMNIA (Could not sleep) and HEADACHE (Bad headache on left side of head/Bad headache on left side of eye/ Headache lasted all night). On 06-Jun-2021, the patient experienced EYE SWELLING (Left eye swollen), SKIN MASS (Started noticing bumps) and RASH (Rash on his forehead above left eye). On 09-Jun-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with PREDNISOLONE at a dose of 1 dosage form and ACYCLOVIR [ACICLOVIR] at a dose of 1 dosage form. At the time of the report, INSOMNIA (Could not sleep), EYE SWELLING (Left eye swollen), HERPES ZOSTER (Shingles), SKIN MASS (Started noticing bumps), MYALGIA (soreness in arm), HEADACHE (Bad headache on left side of head/Bad headache on left side of eye/ Headache lasted all night), FATIGUE (Very Tired) and RASH (Rash on his forehead above left eye) outcome was unknown.             No concomitant Medication was reported by reporter.
Information has been received from a female who on 24-AUG-2007 was vaccinated with a dose of Zostavax (Oka/Merck). On 24-AUG-2007 the patient had a reaction at injection site and on 03-SEP-2007 that patient still had a spot visible at the site that was a size of a half dollar.  A product quality complaint was not involved.  Additional information has been requested.
Onset 1-2 days after second vaccine (on 4/27/2021), has felt ill, has difficulty breathing, cough - deep and strangling, N/V, no fever, but is sweating, out-of-breath with little exertion.  No history of heart or lung problems.  Has not seen a doctor.  Referred to the ER today (6/18/2021).
This prospective pregnancy was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 32-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). The subject's past medical history did not include previous pregnancies. The subject did not use contraception. On 21 April 2014, the subject received unspecified dose of BOOSTRIX (.5 ml, intramuscular, unknown injection site). Her last menstrual period was on 25 September 2013 and estimated date of delivery was on 02 July 2014. It was a normal conception. The subject was exposed to the vaccine during the third trimester. During the prenatal testing performed no evidence of a defect were observed. At the time of reporting the pregnancy was ongoing. Follow-up information received on 23 September 2014 from a nurse: Some of the subject's details and VAERS details were provided. This pregnancy was a normal conception. On 24 June 2014, after 39 weeks gestation, the subject gave birth to a male live infant without congenital anomaly, by cesarean section. The infant had an Apgar score of [1-7], a weight of 3.305 kg. The height of birth and the cranial circumference were not available. Follow-up information received on 29 September 2014: No new information was reported (duplicate Pregnancy Outcome form received).
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients' were vaccinated with improperly stored doses of ROTATEQ (dose and route not reported) from lot # L033543 with expiry date of 30-MAY-2017 and from lot # M025565 with expiry date of 06-NOV-2017. The vaccines were exposed to temperature of 33 degree Fahrenheit (F) for 116 hours (8 occurrences of 14.5 hours each) and 47 F for 116 hours (8 occurrences of 14.5 hours each). No adverse effects were reported. Digital data logger was not involved. There was no previous temperature excursion. Product quality complaint was not involved. This is one of the three reports received from the same reporter. Additional information has been requested.
shock pains in back and neck that lasted for months; numbness in lower legs; headache; fatigue; felt ill; shock pains in back and neck that lasted for months; tngling and numbness in lower legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), NECK PAIN (shock pains in back and neck that lasted for months) and HYPOAESTHESIA (numbness in lower legs) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. didnt know) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 31-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), HEADACHE (headache) and FATIGUE (fatigue). On an unknown date, the patient experienced NECK PAIN (shock pains in back and neck that lasted for months) and HYPOAESTHESIA (numbness in lower legs). At the time of the report, MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), NECK PAIN (shock pains in back and neck that lasted for months), HYPOAESTHESIA (numbness in lower legs), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. Doctor offered to take gabapentine for the tingling and numbness
Patient presented to the ED on 3/9/21 and was admitted to the hospital. He also presented to the ED on 3/30/21 and was subsequently admitted to the hospital. He has been hospitalized ever since.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 73 year-old female patient received bnt162b2 (BNT162B2), administration date 15Mar2021 (Lot number: EN6207) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes mellitus" (ongoing), notes: Onset probably 10 years ago; "Kidney disease" (ongoing), notes: Onset date was probably a long time ago but she was just diagnosed like a year ago. The patient's concomitant medications were not reported. Past drug history included: Tetracycline, reaction(s): "Tetracycline allergy". The following information was reported: FATIGUE (non-serious) with onset 15Mar2021, outcome "recovering", described as "she was kind of tired so she went to bed"; FEELING COLD (non-serious) with onset 15Mar2021, outcome "recovering", described as "proceeded to get colder/she got cold"; CHILLS (non-serious) with onset 15Mar2021, outcome "recovering", described as "shiver"; HYPERHIDROSIS (non-serious) with onset 15Mar2021, outcome "recovering", described as "sweat"; MUSCLE SPASMS (non-serious) with onset 15Mar2021, outcome "recovering", described as "charley horses in her legs"; OROPHARYNGEAL PAIN (non-serious) with onset 16Mar2021, outcome "not recovered", described as "sore throat". Additional information: It was reported that patient received the first dose on 15Mar2021, around 14:00, at upper left shoulder. Patient did not received any other Pfizer vaccine on the same date of BNt162b2 administration. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that starting last night on 15Mar2021 at unknown time, patient was kind of tired so she went to bed. Sometime in the middle of the night at unknown time she got cold. She put on and extra blanket and proceeded to get colder and started to shiver and sweat which went on most of the night. She also had charley horses in her legs, all up and down her legs that went on all night long. Outcome: She was feeling better at this time, although a little shaky and she woke up with a terrible sore throat this morning (16Mar2021) which remains persistent at this time. Events did not result to emergency room and physician office visit. No follow-up attempts are possible. No further information is expected.
COVID infection following COVID vaccine series 02/26, Pfizer doe #1 03/19, Pfizer dose #2 12/21, Pfizer dose #3 12/26 COVID swab, result: detected 12/23 12/23 ot cc: cough, fatigue exposure: unknown 12/26 pt admit ED cc: "mild sore throat", congested nose, more phlegm in his throat," dx: Covid with respiratory multiplex LOS; 1 day 12/29 clinically resolved
Patient began feeling faint approximately 6 minutes after the shot.  She was allowed to rest on the ground of the pharmacy for approximately 15 minutes post shot.  Her breathing was shallow, but her heart rate was increased rapidly.  She did not allow us to call emergency services.  She did not lose consciousness.
3 hours after receiving the vaccine, my arm became increasingly painful and stiff. I was unable to raise it from my side and was in unbearable pain. I iced it and took ibuprofen every 3 hours for 24 hours. It is now 34 hours after the vaccination and I am able to move my arm now, but still have a lot of pain raising it over my head.
Appearance of painful, pruritic vesicular rash around injection site ~ 24 hours after 2nd COVID vaccination; visiting nurse thought it resembled shingles, offered valtrex, but patient declined.  Rash has been resolving and pain has been improving, but as of last visit in our office on 3/12/21 was still present.
patient felt numbness and went to hospital on 4-6-21. was in hospital for 2 days and treated for a stroke. still in therapy
Syncope occurred immediately after injection.  Patient was seated and physically supported with no injury sustained.  Patient was non-responsive for 10-15 seconds.  Patient became alert shortly thereafter and was given water and sugar.  After 15 to 20 minutes, the patient was able to move and recovered appropriately.
Acute on chronic diastolic congestive heart failure. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Pain at injection site (like bruised); Pain at injection site (like bruised); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Pain at injection site (like bruised)) and VACCINATION SITE PAIN (Pain at injection site (like bruised)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     Concomitant products included ISOSORBIDE NITRATE, PREDNISONE, ESTRADIOL, FAMOTIDINE (PEPCID [FAMOTIDINE]), VITAMIN D NOS and besacare for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE BRUISING (Pain at injection site (like bruised)) and VACCINATION SITE PAIN (Pain at injection site (like bruised)). At the time of the report, VACCINATION SITE BRUISING (Pain at injection site (like bruised)) and VACCINATION SITE PAIN (Pain at injection site (like bruised)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products included besacare.  Treatment information not provided.
Client reported reaction to 1st Covid vaccine during 2nd dose of vaccine. Client reported he woke up at 2:20 am 2 days after receiving first Covid 19 vaccine with itching on head, Rt lateral side of torso and lateral Rt leg. Reports of rash and itching  on head lasted 1 week and rash and itching on Rt lateral torso and Rt lateral leg lasted 2 weeks. Client stated he saw the doctor the week of 1/23/21. took oral Benadryl and topical anti itch cream  for rash and itching.  Client reports he was told it was ok to have 2nd vaccine.
230 voice was very scratchy clearing throat. 330 flushed and itching. Continued and worsening scratchy voice. 630 tongue swelling and weak 7:30 wheezing and used epi-pen Went to ER They asked me questions and administered IV Benadryl famotidine and prednisone
25mg po Benadryl given per vo Dr. at 9:20a -- 9:45 symptoms completely resolved  Treatment dugs:
Six days after the second COVID vaccine, I experienced significant pain in my left arm (injection site), tingling, numbness, etc. Rash and hives covering large parts of my chest, abdomen, back, buttocks, legs, and feet was prominent. Can attach pictures.
Pt woke with redness, warm to touch, swelling on(L) deltoid area on 8/18/11. Advised Ice & TYLENOL if needed. 8.8 x 6cm. Pt able to move arm.
On January 21, 2021 at the Clinic, an PA was administering vaccinations during the morning for a four-hour shift, 8 AM to noon. At the end of her shift, she handed off her vaccines to another vaccinator. The PA had three doses of vaccine drawn up at that time, in syringes, on her desk. When the nurse inspected the syringes, she found 0.4mL of vaccine had been drawn into those syringes rather than the required 0.3mL. The then alerted the APRN, who escalated the situation to the manager. The manager then contacted Quality. The concern was that the PA had been vaccinating patients all morning with an inappropriate dose of vaccine, 0.4mL. After thorough internal investigation, we found that the PA drew up 38 vaccine doses and administered 35 of them. Additionally, based on vial usage for the day and total number of vaccines administered, we have concluded that it is highly unlikely that excess vaccine was administered. This was a near miss event and is being reported out of an abundance of caution.
Information has been received from a health professional concerning a 17 month old female who on 19-FEB-2006 was vaccinated with one dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wister RA 27/3). Concomitant vaccine administered on the same day included a dose of diphtheria toxoid (+) Hib conj vaccine (tet toxoid) (+) pertussis acellular Biken vaccine (+) tetanus toxoid (TRIHIBIT). Concomitant therapy included sulfamethazole/trimethoprim (BACTRIM) for the treatment of bladder reflux. "Within 24 hours of administration", on approximately 20-FEB-2006, the patient developed a maculopapular rash. The patient was treated with oral prednisone and diphenhydramine hydrochloride (BENADRYL). It was reported that the rash resolved after one week. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
After receiving the seasonal flu vaccine around 11:25 am, around 5 pm she developed hives on her chin, she was given Benadryl and she seemed to be okay. On 9/17, around 8 am she was complaining of itching on her great toes, at first glance nothing seemed present, at 8:51 am hives were noticed on her elbows, and knees. Within minutes they continued to spread up and down the arms and legs. Mostly present on the bony prominences. Topical Benadryl was applied. Brought to urgent care, where at this point the hives had spread to the face. Prescribed Dexamethasone. Had that around 3 pm, and around 7:30 pm had a 24hr Zyrtec due to increased itching and some hives re-emerging.  Monday, 9/18, no hives noticed but complaints of itching.
Intense redness and pain with erythema 24 hours afterward, chills and no fevers. Extreme pain and redniess that lasted 5 days, gradually resolved over the week.
Pt received the Pfizer monovalent 6mo - 4yr vaccine instead of the 5-11yr Monovalent vaccine for dose #2
Got 1st shot, noticed a lump under skin, about 1/2 inch deep, lump finally disappeared but now have a blister/bump about 1/4 inch across on arm. Arm was sore yesterday, massaged it and soreness is gone today.  Blister is still there. Shot given on the 15th. I don't usually react to shots.
This spontaneous report as received from a registered nurse refers to a 12 month old patient of unknown gender. Information regarding relevant medical history and concurrent condition were not reported. On 09-NOV-2015 the patient was inadvertently vaccinated with an expired dose of PROQUAD (Merck) (lot # K006770, expiration date 07-NOV-2015, dose and route not reported) as first dose. No adverse effects reported. Additional information has been requested.
pt sent to ED after testing positive for COVID in a local clinic and O2 sats being 70% on RA; c/o dyspnea; O2 supplementation; poor oral intake x 2 wks; ABX given; E.Coli Pneumonia; pt's condition worsened requiring intubation; pt continued to deteriorate and he passed away in the hospital
For a couple of days, I have body ache, feverish, tired the first day after the vaccine. I went to the doctor for regular check, and I addressed those issues at the time. I still don't think it's related to the vaccine.
Weird visual; Tingling in left leg; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in left leg) and VISUAL IMPAIRMENT (Weird visual) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Neuropathy.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PARAESTHESIA (Tingling in left leg). On 13-Feb-2021, the patient experienced VISUAL IMPAIRMENT (Weird visual). On 13-Feb-2021, VISUAL IMPAIRMENT (Weird visual) outcome was unknown. At the time of the report, PARAESTHESIA (Tingling in left leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.